TRIM54 and neoplasm: In vitro and in vivo experiments demonstrate that TRIM54 overexpression in tumor cells facilitates tumorigenesis and intrahepatic metastasis; however, inhibition of TRIM54 significantly suppressed hepatocellular carcinoma progression, which indicates that TRIM54 may be a promising prognostic biomarker for HCC.